Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-290-3 | CAS number: 1119-94-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-07-31 to 2018-09-26
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Dodecyltrimethylammonium bromide
- EC Number:
- 214-290-3
- EC Name:
- Dodecyltrimethylammonium bromide
- Cas Number:
- 1119-94-4
- Molecular formula:
- C15H34N.Br
- IUPAC Name:
- dodecyltrimethylazanium bromide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:WI (Han)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Sulzfeld, Germany
- Age at study initiation: 9 weeks
- Weight at study initiation: The mean initial body weight at the start of study was 162 g (range from 152 to 172 g).
- Fasting period before study: Diet was withheld from about 17 to 20 hours before start of treatment until 4 hours after administration.
- Housing: During the acclimation phase, the three rats per treatment group were group-housed in type IV Makrolon® cages with a shelter on softwood bedding material (ABEDD LTE E-001, ABEDD LAB&VET Service GmbH, Austria). Play tunnels (Ref. 14153, Plexx BV, Netherlands) were placed in the cages as additional enrichment. One day before treatment, the rats were single-housed in type III Makrolon"1 cages with a shelter and a play tunnel on softwood bedding material. Wire grids were placed above the softwood granules. They remained in place until all signs of intoxication had subsided. If no signs of intoxication were seen, the wire grids were removed 4 hours after administration. The rats were kept individually until the end of the observation period. The bedding was changed once a week.
- Diet: The rats received a maintenance diet (VI534, ssniff Spezialdiäten GmbH, Germany) ad libitum.
- Water: Drinking water from the community water supply was offered ad libitum in Makrolon® bottles (BIOSCAPE GmbH, Castrop-Rauxel, Germany). Drinking water was changed at least three times per week.
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.1 - 23.8 °C
- Humidity (%): 46.8 - 64.0%
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0.25% aqueous hydroxypropylcellulose (Methocel® K4M Premium solution, 2.5 g/L distilled water)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 5 g/L (50 mg/kg bw test group); 30 g/L (300 mg/kg bw test group)
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
CLASS METHOD
- Rationale for the selection of the starting dose: Due to the fact, that information concerning the toxic potential of the test item after intravenous administration is available (TSCA Chemical Substance Inventory), the study was started in 3 females with 50 mg/kg body weight.
- Doses:
- 50 and 300 mg/kg bw
- No. of animals per sex per dose:
- 50 mg/kg bw: 6 female rats per dose
300 mg/kg bw: 3 female rats per dose - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations and weighing:
Body weight: All animals were weighed before treatment (day 1) and on day 2, 4, 6, 8, 11, 13 and 15.
Mortality and Clinical Signs: On the day of treatment, each animal was observed for mortality and for symptoms of intoxication at scheduled intervals according to the record sheets. On the following days, the rats were examined once daily. Symptoms were recorded individually for each animal.
- Necropsy of survivors performed: yes
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 50 - < 300 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was seen after treatment with 50 mg/kg bw during the course of this study. Two out of three rats treated with 300 mg/kg bw died on day 1 (animal no. 9) and day 2 (animal no. 8), respectively. The third rat (animal no. 7) treated with 300 mg/kg bw was killed in moribund condition on day 4.
- Clinical signs:
- other: No clinical signs of toxicity were observed after treatment with 50 mg/kg bw. All rats treated with 300 mg/kg bw showed salivation 15 minutes after treatment. Animal no. 8 treated with 300 mg/kg bw showed locomotor disturbance on day 2 and animal no. 7 tr
- Gross pathology:
- At gross pathology, no abnormalities were detected in those animals that died. Animal no. 7 exhibited a red nodule within the forestomach, caseous content in the intestine and an enlarged mesenteric lymph node.
At histopathology, a severe purulent inflammation with multiple pustules, hemorrhages and ulceration was observed in the forestomach. The intestinal tract showed marked villous atrophy with granulocytic infiltrates, increased single cell necrosis and apical epithelial hypertrophy. In the mesenteric lymph node, a mild sinusoidal edema was seen. Taken together, the test item induced a purulent gastroenteritis, most likely due to local irritative properties.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- Under the conditions of the present study, the LD50 value for dodecyltrimethylammonium bromide is expected to be between 50 - 300 mg/kg bw after single oral administration in rats.
- Executive summary:
An acute oral toxicity study with the test item, dodecyltrimethylammonium bromide, was performed according to the Acute-Toxic-Class Method and OECD Guideline 423. The study was started with 50 mg/kg in 3 female rats, continued with further 3 females treated with 50 mg/kg bw. Due to the fact, that no mortality was seen after treatment with 50 mg/kg bw, 3 further females were treated with 300 mg/kg bw. Mortality and clinical signs were monitored for at least 6 hours after administration and then daily. All animals were weighed before treatment (day 1) and on days 2, 4, 6, 8, 11, 13, and 15. At the end of the observation period, all surviving rats were sacrificed and subjected to a detailed necropsy.
No mortality was seen after treatment with 50 mg/kg bw during the course of this study. Two out of three rats treated with 300 mg/kg bw died on day 1 (animal no. 9) and day 2 (animal no. 8), respectively. The third rat (animal no. 7) treated with 300 mg/kg bw was killed in moribund condition on day 4. No clinical signs of toxicity were observed after treatment with 50 mg/kg bw. All rats treated with 300 mg/kg bw showed salivation 15 minutes after treatment. Animal no. 8 treated with 300 mg/kg bw showed locomotor disturbance on day 2 and animal no. 7 treated with 300 mg/kg bw showed locomotor disturbance on day 4. The body weight development of all rats treated with 50 mg/kg bw was inconspicuous throughout the study. Animal no. 8 treated with 300 mg/kg bw showed a decrease of body weight on day 2 and animal no. 7 treated with 300 mg/kg bw showed a decrease of body weight on day 4. At gross pathology, no abnormalities were detected in those animals that died. Animal no. 7 exhibited a red nodule within the forestomach, caseous content in the intestine and an enlarged mesenteric lymph node. At histopathology, a severe purulent inflammation with multiple pustules, hemorrhages and ulceration was observed in the forestomach. The intestinal tract showed marked villous atrophy with granulocytic infiltrates, increased single cell necrosis and apical epithelial hypertrophy. In the mesenteric lymph node, a mild sinusoidal edema was seen. Taken together, the test item induced a purulent gastroenteritis, most likely due to local irritative properties.
Under the conditions of the present study, the LD50 value for dodecyltrimethylammonium bromide is expected to be between 50 - 300 mg/kg bw after single oral administration in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.